A Study for QOL and Surgical Incision Pain in Patients Undergoing Totally Thoracoscopic Combined Aortic and Mitral Valve Replacement Surgery
DOI:
https://doi.org/10.1532/hsf.5411Keywords:
totally thoracoscopic, double-valve surgery, quality of life, SF-36, VASAbstract
Background: In recent years, based on traditional median sternotomy surgery, totally thoracoscopic for aortic and mitral valve replacement surgery is increasingly being performed despite little published evidence. This study investigated postoperative pain and short-term quality of life (QOL) of patients undergoing double valve replacement surgery. Methods: From November 2021 to December 2022, 141 patients with double valvular heart disease who underwent thoracoscopic group (N = 62) and median sternotomy group (N = 79) were included. Clinical data were recorded, and a visual analog scale (VAS) was used to measure postoperative pain intensity. The medical outcomes study (MOS) 36-item Short-Form Health Survey assessed short-term QOL after surgery. Results: Sixty-two patients underwent total thoracic double valve replacement, and 79 patients underwent median sternotomy double valve replacement. Both groups were similar in terms of demographics and general clinical data, as well as the incidence of postoperative adverse events. The VAS scores of the thoracoscopic group were lower than those in the median sternotomy group. The hospital stay time was significantly shorter in the thoracoscopic group than in the median sternotomy group (30.2 ± 12 days vs. 36 ± 19 days, p = 0.03). The scores of bodily pains and some of the subscales in SF-36 were significantly different between the two groups (p < 0.05). Conclusions: Thoracoscopic combined aortic and mitral valve replacement surgery can reduce postoperative pain and improve short-term postoperative QOL, which has specific clinical application value.
References
Bendixen M, Jørgensen OD, Kronborg C, Andersen C, Licht PB. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. The Lancet. Oncology. 2016; 17: 836–844.
Casselman FP, La Meir M, Jeanmart H, Mazzarro E, Coddens J, Van Praet F, et al. Endoscopic mitral and tricuspid valve surgery after previous cardiac surgery. Circulation. 2007; 116: I270–I275.
Egea CJ, Aizpuru F, Pinto JA, Ayuela JM, Ballester E, Zamarrón C, et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Medicine. 2008; 9: 660–666.
Failde I, Medina P, Ramírez C, Arana R. Assessing health-related quality of life among coronary patients: SF-36 vs SF-12. Public Health. 2009; 123: 615–617.
Feltner C, Wallace IF, Aymes S, Cook Middleton J, Hicks KL, Schwimmer M, et al. Screening for Obstructive Sleep Apnea in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. The Journal of the American Medical Association. 2022; 328: 1951–1971.
Gadjradj PS, Rubinstein SM, Peul WC, Depauw PR, Vleggeert-Lankamp CL, Seiger A, et al. Full endoscopic versus open discectomy for sciatica: randomised controlled non-inferiority trial. British Medical Journal. 2022; 376: e065846.
Huang LC, Chen DZ, Chen LW, Xu QC, Zheng ZH, Dai XF. Health-related quality of life following minimally invasive totally endoscopic mitral valve surgery. Journal of Cardiothoracic Surgery. 2020; 15: 194.
Issa Y, Kempeneers MA, Bruno MJ, Fockens P, Poley JW, Ahmed Ali U, et al. Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial. The Journal of the American Medical Association. 2020; 323: 237–247.
Kang DH, Park SJ, Rim JH, Yun SC, Kim DH, Song JM, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation. 2010; 121: 1502–1509.
Lacson E, Jr, Xu J, Lin SF, Dean SG, Lazarus JM, Hakim RM. A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clinical Journal of the American Society of Nephrology. 2010; 5: 252–260.
Ma ZS, Yin QY, Dong MF, Feng ZY, Wang LX. Quality of life in patients undergoing totally thoracoscopic closure for atrial septal defect. The Annals of Thoracic Surgery. 2011; 92: 2230–2234.
Mihaljevic T, Jarrett CM, Gillinov AM, Williams SJ, DeVilliers PA, Stewart WJ, et al. Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. The Journal of Thoracic and Cardiovascular Surgery. 2011; 141: 72–80.e1–e4.
Moisset X, Attal N, Ciampi de Andrade D. An Emoji-Based Visual Analog Scale Compared With a Numeric Rating Scale for Pain Assessment. The Journal of the American Medical Association. 2022; 328: 1980.
Nguyen V, Willner N, Eltchaninoff H, Burwash IG, Michel M, Durand E, et al. Trends in aortic valve replacement for aortic stenosis: a French nationwide study. European Heart Journal. 2022; 43: 666–679.
Ogami T, Yokoyama Y, Takagi H, Serna-Gallegos D, Ferdinand FD, Sultan I, et al. Minimally invasive versus conventional aortic valve replacement: The network meta-analysis. Journal of Cardiac Surgery. 2022; 37: 4868–4874.
Paul S, Lee PC, Mao J, Isaacs AJ, Sedrakyan A. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis. British Medical Journal. 2016; 354: i3570.
Stoll C, Schelling G, Goetz AE, Kilger E, Bayer A, Kapfhammer HP, et al. Health-related quality of life and post-traumatic stress disorder in patients after cardiac surgery and intensive care treatment. The Journal of Thoracic and Cardiovascular Surgery. 2000; 120: 505–512.
Wu Q, Shen Y, Xie L, Zhang J, Qiu Z, Tang M, et al. Low acceptance rate of COVID-19 vaccination and reduced quality of life among heart transplant recipients during the COVID-19 pandemic. Journal of Cardiac Surgery. 2022; 37: 4975–4981.
Yaqub F. Thoracoscopic lobectomy versus thoracotomy for NSCLC. The Lancet. Oncology. 2014; 15: e535.
